Market Access and Patient Activation
Delivering end-to-end services to ensure patients in the UK get efficient access to pharmaceutical therapeutics and diagnostics.


In our latest episode in the Making Market Access Real series, our team discuss the changes the NHS will face in 2024 and the impact this will have on access to medicines. Speakers: Laura Norton, Chief Operating Officer, North West Leicestershire GP Federation, Stephen Jowett, Senior director, Market Access & Patient Activation, IQVIA, Arlene Neville, Associate Director - NHS Partnership and Engagement Lead, IQVIA
Delivering end-to-end services to ensure patients in the UK get efficient access to pharmaceutical therapeutics and diagnostics.